 ANI Pharmaceuticals, Inc. ANI or the Company Nasdaq: ANIP today announced that Nikhil Lalwani has been named the Companys President and Chief Executive Officer, effective September 8, 2020. Mr. Lalwani will also be elected to the Companys Board of Directors, effective upon his start date. Mr. Lalwani will succeed Patrick D. Walsh, who will continue to serve as Interim President and CEO until Mr. Lalwani joins the Company and who will remain as Chairman of the Board. 